Despite the incredible, often
life-saving benefits of medical devices such as pacemakers, stents,
catheters, implants, etc., the companies who manufacture them have a big
tax bull's-eye on their backs courtesy of Obamacare.
The Affordable Care Act (ACA) has a provision in it called the
medical device tax, which is a 2.3% excise tax on a wide variety of
medical devices, including most of the products sold by one of the
biggest, and in my view, best, companies in the space:
Medtronic (NYSE: MDT).
Fortunately for Medtronic, and partially because of the industry's
aggressive lobbying, the medical device tax could soon be erased from
Obamacare. That's because, in a rare display of bipartisanship in
Congress, lawmakers from both sides of the political aisle want to
repeal the tax.
(more)
Please share this article
%2Bstock%2Bchart.png)
